The combined HR for the six studies evaluating PD-L1 expression and it relationship with OS was 1.30 (95% CI: 1.02–1.65, P = 0.032), suggesting that high/positive PD-L1 expression is an indicator of a poor prognosis in glioma patients. The gene discussed is CD274; the disease is central nervous system cancer.